BLIS Technologies (NZSE:BLT) Net Margin %: 4.38% (As of Mar. 2026) — 11% Below Median


What is BLIS Technologies Net Margin %?

BLIS Technologies NZSE:BLT Net Margin % is 4.38% as of Mar. 2026, which is 11% below its 10-year median of 4.93. The stock has 4 warning signs investors should review. Among 946 Biotechnology companies, BLIS Technologies ranks better than 76.11% on this metric.

Net margin is calculated as Net Income divided by its Revenue. BLIS Technologies's Net Income for the six months ended in Mar. 2026 was NZ$0.27 Mil. BLIS Technologies's Revenue for the six months ended in Mar. 2026 was NZ$6.23 Mil. Therefore, BLIS Technologies's net margin for the quarter that ended in Mar. 2026 was 4.38%.

The historical rank and industry rank for BLIS Technologies's Net Margin % or its related term are showing as below:

NZSE:BLT' s Net Margin % Range Over the Past 10 Years
Min: -30.77   Med: 4.93   Max: 15.34
Current: 5.16

NZSE:BLT's Net Margin % is ranked better than
76.11% of 946 companies
in the Biotechnology industry
Industry Median: -88.815 vs NZSE:BLT: 5.16

BLIS Technologies  (NZSE:BLT) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

BLIS Technologies Net Margin % Related Terms

BLIS Technologies Net Margin % Historical Data

* Premium members only.

The historical data trend for BLIS Technologies's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BLIS Technologies Net Margin % Chart

BLIS Technologies Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -30.77 -13.57 6.16 7.25 5.16

BLIS Technologies Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.26 4.10 10.19 5.84 4.38

NZSE:BLT vs VRTX, REGN, ALNY: Net Margin % Comparison

For the Biotechnology subindustry, BLIS Technologies's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BLIS Technologies Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BLIS Technologies's Net Margin % distribution charts can be found below:

* The bar in red indicates where BLIS Technologies's Net Margin % falls into.


BLIS Technologies Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

BLIS Technologies's Net Margin for the fiscal year that ended in Mar. 2026 is calculated as

Net Margin=Net Income (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=0.692/13.404
=5.16 %

BLIS Technologies's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=0.273/6.233
=4.38 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 4.38% mean?
BLIS Technologies (NZSE:BLT) has a Net Margin % of 4.38% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on BLIS Technologies and its competitors. This is 11% below median its historical median of 4.93. According to the industry distribution chart, BLIS Technologies ranks #226 out of 946 companies in the Biotechnology industry, placing it in the top 23.9%.
Is BLIS Technologies' Net Margin % too high?
BLIS Technologies' current Net Margin % of 4.38% is 11% below median its 10-year median of 4.93. Based on the distribution chart, BLIS Technologies ranks #226 out of 946 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does BLIS Technologies' Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BLIS Technologies ranks #226 out of 946 companies for Net Margin %. This places BLIS Technologies in the top 24% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on BLIS Technologies and its competitors. BLIS Technologies's current Net Margin % is 4.38%, which is 11% below median its own 10-year median of 4.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BLIS Technologies stock overvalued right now?
Based on GuruFocus' analysis, BLIS Technologies (NZSE:BLT) is currently considered Modestly Undervalued. The stock's GF Value™ is NZ$0.02, compared to a current price of NZ$0.02 — trading 20% below its estimated fair value. The current Net Margin % is 4.38%, which is 11% below median its 10-year median of 4.93. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For BLIS Technologies (NZSE:BLT), the current Net Margin % is 4.38% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BLIS Technologies Business Description

Address 399 Moray Place, Dunedin Central, Dunedin, OTA, NZL, 9016
BLIS Technologies Ltd is engaged in developing oral probiotics. The company markets strains of probiotic bacteria BLIS K12, BLIS Q24, and BLIS M18, which occur naturally in the oral cavity. Its product portfolio consists of probiotic serum, Teeth and gums lozenge, fresh breath lozenge, and immune lozenge. Geographically, the company derives a majority of its revenue from North America. The company also generates a small portion of revenue from Non-core business, which includes grants and interest revenue.